Five days of oral topotecan (hycamtin ( R)), a phase I and pharmacological study in adult patients with solid tumours

By Gerrits C.J.H.   Burris H.   Schellens J.H.M.   Planting A.S.T.   van den Burg M.E.L.   Rodriguez G.I.   van Beurden V.   Loos W.J.   Hudson I.   Fields S.   Verweij J.   von Hoff D.D.  

European Journal of Cancer, Vol. 34, Iss. 7, 1998-06 ,pp. : 1030-1035

Elsevier

Access to resources Recommend Favorite

Trends of oral and oropharyngeal cancer survival over five decades in 3267 patients treated in a single institution

By Carvalho A.L.   Ikeda M.K.   Magrin J.   Kowalski L.P.  

Oral Oncology, Vol. 40, Iss. 1, 2004-01 ,pp. : 71-76

Elsevier

Access to resources Recommend Favorite

Thrombolytic and anticoagulant therapy for acute submassive pulmonary embolism

By                        

Experimental and Therapeutic Medicine, Vol. 7, Iss. 1, 2014-01 ,pp. : 103-108

Spandidos Publications

Access to resources Recommend Favorite

Identification of a High-Risk Subgroup of Patients with Resected pT3 Oral Cavity Cancer in Need of Postoperative Adjuvant Therapy

By Liao Chun-Ta  

Annals of Surgical Oncology, Vol. 18, Iss. 9, 2011-09 ,pp. : 2569-2578

Springer Publishing Company

Access to resources Recommend Favorite

Local antimicrobial therapy of oral mucositis in paediatric patients undergoing bone marrow transplantation

By Bondi E.   Baroni C.   Prete A.   Gatti M.   Carrassi A.   Lodi G.   Porter S.R.  

European Journal of Cancer. Part B: Oral Oncology, Vol. 33, Iss. 5, 1997-09 ,pp. : 322-326

Elsevier

Access to resources Recommend Favorite